Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Do Age, Fitness and Concomitant Medications Influence Management and Outcomes of CLL Patients Treated with Ibrutinib?

Blood (2020) 136 (Supplement 1): 54–55.

https://doi.org/10.1182/blood-2020-137024

Published: 2020

Journal Articles

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Augusto B. Federici, MD, Maria C Carraro, Antonella Lattuada, Chiara Vanelli, Veronica Sciumbata, Valentina Rossi, MD, Daniela Intini, Sarah Birindelli, Sara Munizza, Elisabetta Sacchi, Umberto Russo, Ulrich Budde, MD

Blood (2012) 120 (21): 3369.

https://doi.org/10.1182/blood.V120.21.3369.3369

Published: 2012

Journal Articles

Computed Tomography (CT) Scan Response Stability and Gallium Scan Evaluation as On-Treatment Prognostic Parameters To Tailor Treatment Intensity of Newly Diagnosed Hodgkin’s Lymphoma (HL). A Prospective Phase II Study.

Alessandro Re, MD, Samantha Ferrari, MD, Paolo Frata, MD, Claudio Pizzocaro, MD, Fabio Franco, MD, Valentina Rossi, MD, AnnaMaria Pelizzari, MD, Claudia Crippa, MD, Nicoletta Petrella, MD, Alessandra Tucci, MD, Fabio Facchetti, MD, PhD, Luigi Grazioli, MD, Stefano Magrini, MD, PhD, Giuseppe Rossi, MD

Blood (2005) 106 (11): 2669.

https://doi.org/10.1182/blood.V106.11.2669.2669

Published: 2005

Journal Articles

Adult Onset of Hemophagocytic Syndrome: Report of 13 Cases from a Single Institution.

Valentina Rossi, MD, Chiara Cattaneo, MD, Alessandro Re, MD, Giulia Quaresmini, MD, Davide Bertelli, MD, Ottorino Barozzi, MD, Benvenuto Antonini, MD, Mario Luppi, MD, Giuseppe Rossi, MD

Blood (2005) 106 (11): 3880.

https://doi.org/10.1182/blood.V106.11.3880.3880

Published: 2005

Journal Articles

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Ester Pungolino, MD, Michela Draisci, MD, Livio Gargantini, MD, Renata Farioli, PhD, Valentina Rossi, MD, Paola Cozzi, MD, Sara Miqueleiz Alamos, MD, Anna Maria Cafro, MD, Enrica Morra, MD

Blood (2004) 104 (11): 4690.

https://doi.org/10.1182/blood.V104.11.4690.4690

Published: 2004

Journal Articles

Alemtuzumab as Consolidation after a Response to Fludarabine Is Effective To Purge Residual Disease in Patients with Chronic Lymphocytic Leukemia.

Marco Montillo, MD, Alessandra Tedeschi, MD, Valentina Rossi, MD, Anna Maria Cafro, MD, Roberto Cairoli, MD, Silvio Veronese, PhD, Barbara Scarpati, PhD, Renata Farioli, PhD, Mario Regazzi, MD, Marcello Gambacorta, MD, Enrica Morra, MD

Blood (2004) 104 (11): 479.

https://doi.org/10.1182/blood.V104.11.479.479

Published: 2004

Journal Articles

Management of Cytomegalovirus (CMV) Reactivation in B-CLL Patients Receiving Sequential Treatment with Fludarabine (FAMP) Including Regimens and Alemtuzumab.

Valentina Rossi, MD, Marco Montillo, MD, Alessandra Tedeschi, MD, Anna Maria Cafro, MD, Enrica Morra, MD

Blood (2004) 104 (11): 2521.

https://doi.org/10.1182/blood.V104.11.2521.2521

Published: 2004

Journal Articles

Feasiblity of Autologous Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Sequential Fludarabine and Campath-1H.

Alessandra Tedeschi, MD, Roberto Cairoli, MD, Marco Montillo, MD, Paola Marenco, MD, Giovanni Grillo, MD, Valentina Rossi, MD, Anna Maria Cafro, MD, Liliana Intropido, Enrica Morra, MD

Blood (2004) 104 (11): 1879.

https://doi.org/10.1182/blood.V104.11.1879.1879

Published: 2004

NARROW

Do Age, Fitness and Concomitant Medications Influence Management and Outcomes of CLL Patients Treated with Ibrutinib?

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Computed Tomography (CT) Scan Response Stability and Gallium Scan Evaluation as On-Treatment Prognostic Parameters To Tailor Treatment Intensity of Newly Diagnosed Hodgkin’s Lymphoma (HL). A Prospective Phase II Study.

Adult Onset of Hemophagocytic Syndrome: Report of 13 Cases from a Single Institution.

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Alemtuzumab as Consolidation after a Response to Fludarabine Is Effective To Purge Residual Disease in Patients with Chronic Lymphocytic Leukemia.

Management of Cytomegalovirus (CMV) Reactivation in B-CLL Patients Receiving Sequential Treatment with Fludarabine (FAMP) Including Regimens and Alemtuzumab.

Feasiblity of Autologous Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Sequential Fludarabine and Campath-1H.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only